Abstract
Osteosarcoma (OS) is the most common malignant bone tumor and the majority of recurrences are due to metastasis. However, the molecular mechanisms that regulate OS metastatic spread are largely unknown. In this study, we report that special AT-rich-binding protein 2 (SATB2) is highly expressed in OS cells and tumors. Short hairpin RNA-mediated knockdown of SATB2 (sh-SATB2) decreases migration and invasion of OS cells without affecting proliferation or viability. Microarray analysis identified genes that were differentially regulated by SATB2 including the actin-binding protein Epithelial Protein Lost In Neoplasm (EPLIN), which was upregulated in sh-SATB2 cells. Silencing EPLIN rescues the decreased invasion observed in sh-SATB2 cells. Pathway analyses of SATB2-regulated genes revealed enrichment of those involved in cytoskeleton dynamics, and increased stress fiber formation was detected in cells with SATB2 knockdown. Furthermore, sh-SATB2 cells exhibit increased RhoA, decreased Rac1 and increased phosphorylation of focal adhesion kinase (FAK) and paxillin. These findings identify SATB2 as a novel regulator of OS invasion, in part via effects on EPLIN and the cytoskeleton.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Broadhead ML, Clark JCM, Myers DE, Dass CR, Choong PFM . The molecular pathogenesis of osteosarcoma: a review. Sarcoma 2011; 2011: 1–12.
Britanova O, Depew MJ, Schwark M, Thomas BL, Miletich I, Sharpe P et al. Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development. Am J Hum Genet 2006; 79: 668–678.
Dobreva G, Chahrour M, Dautzenberg M, Chirivella L, Kanzler B, Fariñas I et al. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 2006; 125: 971–986.
Dobreva G . SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin gene expression. Genes Dev 2003; 17: 3048–3061.
Britanova O, de Juan Romero C, Cheung A, Kwan KY, Schwark M, Gyorgy A et al. Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. Neuron 2008; 57: 378–392.
Han H-J, Russo J, Kohwi Y, Kohwi-Shigematsu T . SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452: 187–193.
Chung J, Lau J, Cheng LS, Grant RI, Robinson F, Ketela T et al. SATB2 augments ΔNp63α in head and neck squamous cell carcinoma. EMBO Rep 2010; 11: 777–783.
Aprelikova O, Yu X, Palla J, Wei B-R, John S, Yi M et al. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 2010; 9: 4387–4398.
Patani N, Jiang W, Mansel R, Newbold R, Mokbel K . The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int 2009; 9: 18.
Eberhard J, Gaber A, Wangefjord S, Nodin B, Uhlén M, Ericson Lindquist K et al. A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. Br J Cancer 2012; 106: 931–938.
Olson MF, Sahai E . The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis 2008; 26: 273–287.
Parri M, Chiarugi P . Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 2010; 8: 23.
Zhang S, Wang X, Osunkoya AO, Iqbal S, Wang Y, Chen Z et al. EPLIN downregulation promotes epithelial–mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene 2011; 30: 4941–4952.
Maul RS, Chang DD . EPLIN, epithelial protein lost in neoplasm. Oncogene 1999; 18: 7838–7841.
Abe K, Takeichi M . EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt. Proc Natl Acad Sci USA [Internet] 2007; 105: 13–19. Available from http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18093941&retmode=ref&cmd=prlinks.
Molyneux SD, Di Grappa MA, Beristain AG, McKee TD, Wai DH, Paderova J et al. Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. J Clin Invest 2010; 120: 3310–3325.
Latini FRM, Hemerly JP, Oler G, Riggins GJ, Cerutti JM . Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion. Endocr Relat Cancer 2008; 15: 787–799.
Yuan X, Yu L, Li J, Xie G, Rong T, Zhang L et al. ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton. Cancer Res 2013; 73: 3625–3637.
Zech T, Calaminus SDJ, Caswell P, Spence HJ, Carnell M, Insall RH et al. The Arp2/3 activator WASH regulates 5 1-integrin-mediated invasive migration. J Cell Sci 2011; 124: 3753–3759.
Sahai E, Marshall CJ . RHO-GTPases and cancer. Nat Rev Cancer 2002; 2: 133–142.
Maul RS . EPLIN regulates actin dynamics by cross-linking and stabilizing filaments. J Cell Biol 2003; 160: 399–407.
Satoh Y, Yokota T, Sudo T, Kondo M, Lai A, Kincade PW et al. The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages. Immunity 2013; 38: 1105–1115.
Zhao X, Qu Z, Tickner J, Xu J, Dai K, Zhang X . The role of SATB2 in skeletogenesis and human disease. Cytokine Growth Factor Rev 2014; 25: 35–44.
Leoyklang P, Suphapeetiporn K, Siriwan P, Desudchit T, Chaowanapanja P, Gahl WA et al. Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects. Hum Mutat 2007; 28: 732–738.
Wei J, Shi Y, Zheng L, Zhou B, Inose H, Wang J et al. miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol 2012; 197: 509–521.
Hassan MQ, Gordon JAR, Beloti MM, Croce CM, van Wijnen AJ, Stein JL et al. A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA 2010; 107: 19879–19884.
Conner JR, Hornick JL . SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology 2013; 63: 36–49.
Hall A . The cytoskeleton and cancer. Cancer Metastasis Rev 2009; 28 (1-2): 5–14.
Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004; 10: 182–186.
Zucchini C, Manara MC, Pinca RS, De Sanctis P, Guerzoni C, Sciandra M et al. CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity. Oncogene 2014; 33: 1912–1921.
Steder M, Alla V, Meier C, Spitschak A, Pahnke J, Fürst K et al. DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling. Cancer Cell 2013; 24: 512–527.
Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 2001; 61: 3750–3759.
Flores RJ, Li Y, Yu A, Shen J, Rao PH, Lau SS et al. A systems biology approach reveals common metastatic pathways in osteosarcoma. BMC Syst Biol 2012; 6: 50.
O'Donoghue LE, Ptitsyn AA, Kamstock DA, Siebert J, Thomas RS, Duval DL . Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome. BMC Cancer 2010; 10: 506.
Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012; 72: 1865–1877.
Huveneers S, Danen EHJ . Adhesion signaling—crosstalk between integrins, Src and Rho. J Cell Sci 2009; 122: 1059–1069.
Tsurumi H, Harita Y, Kurihara H, Kosako H, Hayashi K, Matsunaga A et al. Epithelial protein lost in neoplasm modulates platelet-derived growth factor-mediated adhesion and motility of mesangial cells. Kidney Int 2014; 86: 548–557.
Sanders AJ, Ye L, Mason MD, Jiang WG . The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis. Angiogenesis 2010; 13: 317–326.
Quizi JL, Baron K, Al-Zahrani KN, Reilly POA, Sriram RK, Conway J et al. SLK-mediated phosphorylation of paxillin is required for focal adhesion turnover and cell migration. Oncogene 2012; 32: 4656–4663.
Zaidel-Bar R, Milo R, Kam Z, Geiger B . A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions. J Cell Sci 2006; 120: 137–148.
Abou Zeid N, Vallés A-M, Boyer B . Serine phosphorylation regulates paxillin turnover during cell migration. Cell Commun Signal 2006; 4: 8.
Stehn JR, Haass NK, Bonello T, Desouza M, Kottyan G, Treutlein H et al. A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. Cancer Res 2013; 73: 5169–5182.
Schneider CA, Rasband WS, Eliceiri KW . NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671–675.
Merico D, Isserlin R, Stueker O, Emili A, Bader GD . Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE 2010; 5: e13984.
Acknowledgements
This study was supported by funds from the Canadian Cancer Society Research Institute (#2010-700580, MSI), Ontario Research Fund (MSI, DM) and a Canada Research Chair in Cancer Biology (MSI). BKAS and JL received scholarships from Hospital for Sick Children Research Training Centre (Restracomp). We are grateful for assistance with microarray analyses from Daniel Picard and Dr Annie Huang.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Seong, B., Lau, J., Adderley, T. et al. SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization. Oncogene 34, 3582–3592 (2015). https://doi.org/10.1038/onc.2014.289
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2014.289
This article is cited by
-
Selective mediation of ovarian cancer SKOV3 cells death by pristine carbon quantum dots/Cu2O composite through targeting matrix metalloproteinases, angiogenic cytokines and cytoskeleton
Journal of Nanobiotechnology (2021)
-
SATB family chromatin organizers as master regulators of tumor progression
Oncogene (2019)
-
SATB2 suppresses non-small cell lung cancer invasiveness by G9a
Clinical and Experimental Medicine (2018)
-
SATB2 suppresses gastric cancer cell proliferation and migration
Tumor Biology (2016)